1
|
Buscemi S, Orlando E, Damiano G, Portelli
F, Palumbo VD, Valentino A, Marrazzo A, Buscemi G and Lo Monte AI:
‘Pure’ large cell neuroendocrine carcinoma of the gallbladder.
Report of a case and review of the literature. Int J Surg. 28
(Suppl 1):S128–S132. 2016.PubMed/NCBI View Article : Google Scholar
|
2
|
Radović N, Turner R and Bacalja J: Primary
‘pure’ large cell neuroendocrine carcinoma of the urinary bladder:
A case report and review of the literature. Clin Genitourin Cancer.
13:e375–e377. 2015.PubMed/NCBI View Article : Google Scholar
|
3
|
Okoye E, Choi EK, Divatia M, Miles BJ,
Ayala AG and Ro JY: De novo large cell neuroendocrine carcinoma of
the prostate gland with pelvic lymph node metastasis: A case report
with review of literature. Int J Clin Exp Pathol. 7:9061–9066.
2014.PubMed/NCBI
|
4
|
Ki EY, Park JS, Lee KH, Bae SN and Hur SY:
Large cell neuroendocrine carcinoma of the ovary: A case report and
a brief review of the literature. World J Surg Oncol.
12(314)2014.PubMed/NCBI View Article : Google Scholar
|
5
|
Kawaratani H, Tsujimoto T, Yoshikawa M,
Kawanami F, Shirai Y, Yoshiji H, Morita K and Fukui H: Large cell
neuroendocrine carcinoma presenting with neck swelling in the
submandibular gland: A case report. J Med Case Rep.
7(81)2013.PubMed/NCBI View Article : Google Scholar
|
6
|
Ogura J, Adachi Y, Yasumoto K, Okamura A,
Nonogaki H, Kakui K, Yamanoi K, Suginami K, Koyama T and Ikehara S:
Large-cell neuroendocrine carcinoma arising in the endometrium: A
case report. Mol Clin Oncol. 8:575–578. 2018.PubMed/NCBI View Article : Google Scholar
|
7
|
Kobayashi A, Yahata T, Nanjo S, Mizoguchi
M, Yamamoto M, Mabuchi Y, Yagi S, Minami S and Ino K: Rapidly
progressing large-cell neuroendocrine carcinoma arising from the
uterine corpus: A case report and review of the literature. Mol
Clin Oncol. 6:881–885. 2017.PubMed/NCBI View Article : Google Scholar
|
8
|
Gu J, Gong D, Wang Y, Chi B, Zhang J, Hu S
and Min L: The demographic and treatment options for patients with
large cell neuroendocrine carcinoma of the lung. Cancer Med.
8:2979–2993. 2019.PubMed/NCBI View Article : Google Scholar
|
9
|
Naidoo J, Santos-Zabala ML, Iyriboz T, Woo
KM, Sima CS, Fiore JJ, Kris MG, Riely GJ, Lito P, Iqbal A, et al:
Large Cell neuroendocrine carcinoma of the lung: Clinico-pathologic
features, treatment, and outcomes. Clin Lung Cancer. 17:e121–e129.
2016.PubMed/NCBI View Article : Google Scholar
|
10
|
Gollard R, Jhatakia S, Elliott M and Kosty
M: Large cell/neuroendocrine carcinoma. Lung Cancer. 69:13–18.
2010.PubMed/NCBI View Article : Google Scholar
|
11
|
Xuan WX, Li JJ, Shi YJ and Zhang XJ:
Atypical carcinoid: A rare finding of a man with mediastinal mass:
A case report. Mol Clin Oncol. 12:325–328. 2020.PubMed/NCBI View Article : Google Scholar
|
12
|
Melosky B: Advanced typical and atypical
carcinoid tumours of the lung: Management recommendations. Curr
Oncol. 25 (Suppl 1):S86–S93. 2018.PubMed/NCBI View Article : Google Scholar
|
13
|
Hiroshima K and Mino-Kenudson M: Update on
large cell neuroendocrine carcinoma. Transl Lung Cancer Res.
6:530–539. 2017.PubMed/NCBI View Article : Google Scholar
|
14
|
Bari MF, Brown H, Nicholson AG, Kerr KM,
Gosney JR, Wallace WA, Soomro I, Muller S, Peat D, Moore JD, et al:
BAI3, CDX2 and VIL1: A panel of three antibodies to distinguish
small cell from large cell neuroendocrine lung carcinomas.
Histopathology. 64:547–556. 2014.PubMed/NCBI View Article : Google Scholar
|
15
|
Filosso PL, Rena O, Guerrera F, Moreno
Casado P, Sagan D, Raveglia F, Brunelli A, Welter S, Gust L,
Pompili C, et al: Clinical management of atypical carcinoid and
large-cell neuroendocrine carcinoma: A multicentre study on behalf
of the European Association of Thoracic Surgeons (ESTS)
neuroendocrine tumours of the lung working group. Eur J
Cardiothorac Surg. 48:55–64. 2015.PubMed/NCBI View Article : Google Scholar
|
16
|
Asamura H, Kameya T, Matsuno Y, Noguchi M,
Tada H, Ishikawa Y, Yokose T, Jiang SX, Inoue T, Nakagawa K, et al:
Neuroendocrine neoplasms of the lung: A prognostic spectrum. J Clin
Oncol. 24:70–76. 2006.PubMed/NCBI View Article : Google Scholar
|
17
|
Rossi G, Bertero L, Marchiò C and Papotti
M: Molecular alterations of neuroendocrine tumours of the lung.
Histopathology. 72:142–152. 2018.PubMed/NCBI View Article : Google Scholar
|
18
|
Rekhtman N, Pietanza MC, Hellmann MD,
Naidoo J, Arora A, Won H, Halpenny DF, Wang H, Tian SK, Litvak AM,
et al: Next-generation sequencing of pulmonary large cell
neuroendocrine carcinoma reveals small cell carcinoma-like and
non-small cell carcinoma-like subsets. Clin Cancer Res.
22:3618–3629. 2016.PubMed/NCBI View Article : Google Scholar
|
19
|
Miyoshi T, Umemura S, Matsumura Y, Mimaki
S, Tada S, Makinoshima H, Ishii G, Udagawa H, Matsumoto S, Yoh K,
et al: Genomic profiling of large-cell neuroendocrine carcinoma of
the lung. Clin Cancer Res. 23:757–765. 2017.PubMed/NCBI View Article : Google Scholar
|
20
|
Filosso PL, Guerrera F, Evangelista A,
Galassi C, Welter S, Rendina EA, Travis W, Lim E, Sarkaria I,
Thomas PA, et al: Adjuvant chemotherapy for large-cell
neuroendocrine lung carcinoma: Results from the European Society
for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective
Database. Eur J Cardiothorac Surg. 52:339–345. 2017.PubMed/NCBI View Article : Google Scholar
|
21
|
Prelaj A, Rebuzzi SE, Del Bene G, Giròn
Berrìos JR, Emiliani A, De Filippis L, Prete AA, Pecorari S, Manna
G, Ferrara C, et al: Evaluation of the efficacy of
cisplatin-etoposide and the role of thoracic radiotherapy and
prophylactic cranial irradiation in LCNEC. ERJ Open Res.
3:00128–2016. 2017.PubMed/NCBI View Article : Google Scholar
|
22
|
Cao L, Zhao L, Wang M, Zhang XH, Yang ZC
and Liu YP: Clinicopathological characteristics and prognosis of
pulmonary large cell neuroendocrine carcinoma aged 65 years. PeerJ.
7(e6824)2019.PubMed/NCBI View Article : Google Scholar
|
23
|
Sun JM, Ahn MJ, Ahn JS, Um SW, Kim H, Kim
HK, Choi YS, Han J, Kim J, Kwon OJ, et al: Chemotherapy for
pulmonary large cell neuroendocrine carcinoma: Similar to that for
small cell lung cancer or non-small cell lung cancer? Lung Cancer.
77:365–370. 2012.PubMed/NCBI View Article : Google Scholar
|
24
|
Rieber J, Schmitt J, Warth A, Muley T,
Kappes J, Eichhorn F, Hoffmann H, Heussel CP, Welzel T, Debus J, et
al: Outcome and prognostic factors of multimodal therapy for
pulmonary large-cell neuroendocrine carcinomas. Eur J Med Res.
20(64)2015.PubMed/NCBI View Article : Google Scholar
|
25
|
Daido W, Yamasaki M, Saito N, Ishiyama S,
Deguchi N, Taniwaki M, Daga H and Ohashi N: Effectiveness of
nivolumab in large-cell neuroendocrine carcinoma of the lung-A
report of two cases. Gan To Kagaku Ryoho. 44:59–62. 2017.PubMed/NCBI(In Japanese).
|
26
|
Derks JL, Leblay N, Thunnissen E, van
Suylen RJ, den Bakker M, Groen HJM, Smit EF, Damhuis R, van den
Broek EC, Charbrier A, et al: Molecular subtypes of pulmonary
large-cell neuroendocrine carcinoma predict chemotherapy treatment
outcome. Clin Cancer Res. 24:33–42. 2018.PubMed/NCBI View Article : Google Scholar
|
27
|
Takezawa K, Okamoto I, Fukuoka J, Tanaka
K, Kaneda H, Uejima H, Yoon HE, Imakita M, Fukuoka M and Nakagawa
K: Large cell neuroendocrine carcinoma of the mediastinum with
alpha-fetoprotein production. J Thorac Oncol. 3:187–189.
2008.PubMed/NCBI View Article : Google Scholar
|
28
|
Juanpere S, Cañete N, Ortuño P, Martínez
S, Sanchez G and Bernado L: A diagnostic approach to the
mediastinal masses. Insights Imaging. 4:29–52. 2013.PubMed/NCBI View Article : Google Scholar
|
29
|
Almeida PT and Heller D: Anterior
Mediastinal Mass. In: StatPearls (Internet). Available from:
urihttps://www.ncbi.nlm.nih.gov/books/NBK546608/simplehttps://www.ncbi.nlm.nih.gov/books/NBK546608/.
|
30
|
Yendamuri S: Resection of a giant
mediastinal teratoma. Ann Thorac Surg. 102:e401–e402.
2016.PubMed/NCBI View Article : Google Scholar
|
31
|
Sanchez AIP, Roces LV, Garcia IZ, Lopez
EL, Hernandez MAC, Parejo MIB and Pena-Diaz J: Value of
α-fetoprotein as an early biomarker for treatment response to
sorafenib therapy in advanced hepatocellular carcinoma. Oncol Lett.
15:8863–8870. 2018.PubMed/NCBI View Article : Google Scholar
|